Is the BHP share price in the buy zone?

The BHP Group Ltd (ASX:BHP) share price is dropping lower on Wednesday. Is this a buying opportunity for investors?

The BHP Group Ltd (ASX: BHP) share price has come under pressure on Wednesday and dropped lower.

In afternoon trade the mining giant's shares have fallen over 3% to $37.59.

Is this a buying opportunity?

One leading broker that sees the BHP share price weakness as a buying opportunity is Ord Minnett.

This morning the broker retained its accumulate rating and $42.00 price target. This price target implies potential upside of almost 12% for its shares over the next 12 months.

If you add dividends into the equation, this potential return stretches to upwards of ~16%.

According to the note, BHP's iron ore production and shipments came in ahead of the broker's forecasts during the June quarter. Though, the average price realised of US$77.36 a tonne, was a touch short of expectations.

Looking ahead, the broker feels that the mining giant's iron ore production guidance of 244 Mt to 253 Mt and shipments guidance of 276 Mt to 286 Mt for FY 2021 might prove too conservative.

In light of this and strong iron ore prices, the broker sees potential upside risk to its earnings estimates for the year ahead.

Combined with its favourable commodity mix, attractive valuation, and outlook, it continues with its positive rating on the company's shares.

Should you invest?

I agree with Ord Minnett and would be a buyer of BHP's shares right now.

While I also like Fortescue Metals Group Limited (ASX: FMG) and Rio Tinto Limited (ASX: RIO), BHP remains my preferred pick due to the diversification of its operations, its strong balance sheet, and its growth opportunities.

Another positive is its dividend yield. The consensus estimate is for a fully franked dividend yield of over 4% in FY 2021. However, if iron ore prices remain strong, I suspect this yield could be even more generous.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Two colleagues looking at a graph and comparing share prices.
Broker Notes

Buy, hold, sell: Orica, Bank of Queensland, Megaport shares

Morgans has just released new notes and ratings on these 3 ASX 200 shares.

Read more »

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: IDP Education, Macmahon Holdings, Transurban shares

Let's check out some new ratings on ASX shares today.

Read more »

IPO written on a chalk board with a rising rocket.
IPOs

Should you participate in Australia's second-largest IPO in history?

The deal, shaped by hype and controversy, has investors on the edge of their seats.

Read more »

Stressed businessman sits in panic amid digital stock market financial background.
52-Week Lows

NextDC, Generation Development, Fortescue shares hit 52-week low. Can they rebound?

Here’s what the experts think.

Read more »

Woman with her hands out to each side on a light blue background.
ASX Share Market News

The Lottery Corporation vs Aristocrat Leisure: ASX shares compared

Which is better for Aussie investors: The Lottery Corporation’s yield or Aristocrat’s growth? Here’s how the two compare on the…

Read more »

Couple using their digital tablet together.
Broker Notes

Why this top broker is buying Charter Hall, Soul Patts, and Wesfarmers shares

Let's see why Bell Potter is recommending a shift to quality shares.

Read more »

Couple on their laptop in their home kitchen.
ASX Share Market News

5 things to watch on the ASX 200 on Thursday

It looks set to be a tough day for Aussie investors. Here's what to expect.

Read more »

Stethoscope and a pen on a laptop.
Broker Notes

Macquarie tips an 8% dividend yield and 46% share price gain for this stock

This health stock is looking undervalued, the broker says.

Read more »